Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Treatment with the diabetes drug metformin prevented the progression of coronary atherosclerosis in a study of people living with HIV.
People with HIV and metabolic syndrome who combined the diabetes drug Glucophage may be able to stave off signs of cardiovascular disease.
Initiating antiretroviral (ARV) therapy when the CD4 cell count is above 350 is associated with a reduced risk of arterial stiffness.
HIV-positive people are aging faster than those not infected HIV, possibly due to the body’s hyperactive response to the virus.
Increases in homocysteine may help explain the higher rates of arterial disease seen in people living with HIV receiving ARV therapy.
Untreated HIV may increase the risk of artery blockage and blood clots, according to new data from the international Strategies for the Manage...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.